Annual Report
Displaying items 61-71 of 71 in total
X4 Pharma at Guggenheim: High Stakes for its Rare Disease Pipeline
Alfa Laval Profits Rise, But Falling Orders Signal Caution
eQ Profit Falls 21%; New CEO Pivots to Bold 2030 Turnaround Plan
Opera Surges Past Guidance on AI and High-Value User Growth
Air Canada Faces Crucial Test with 2025 Year-End Financial Results
Tallinna Vesi's Moment of Truth: 2025 Results to Cap Pivotal Year
Grønlandsbanken Beats Forecast Amid Greenland's Economic Shift
Silgan's 2025 Earnings: A Test of Resilience in a Shifting Market
Fortis Set to Unveil 2025 Results Amidst $28.8B Strategic Overhaul
Valley Bank Bets on Human Touch to 'Own the Middle' Ground
